| RS1337235778 |
KMT2D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1337256944 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1337287633 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1337293997 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1337305891 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Renal cell carcinoma |
| RS1337343400 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1337345059 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1337346956 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1337363590 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1337364058 |
MERTK
|
Health Risk |
Pathogenic |
— |
| RS1337377726 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1337382297 |
POLR3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, POLR3B-related disorder |
| RS1337409061 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 1, Cardiovascular phenotype |
| RS1337417322 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1337420489 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1337473924 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS1337509224 |
NGLY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of deglycosylation, Inborn genetic diseases |
| RS1337518083 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1337524033 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1337528878 |
POLR3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukodystrophy, Leukodystrophy |
| RS1337554479 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome 1 |
| RS1337556254 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS1337559480 |
C3
|
Health Risk |
Pathogenic/Likely pathogenic |
Complement component 3 deficiency, Age related macular degeneration 9 |
| RS1337598962 |
AKR1D1
|
Health Risk |
Likely pathogenic |
Congenital bile acid synthesis defect 2, Congenital bile acid synthesis defect 2 |
| RS1337628147 |
PGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Intellectual disability |
| RS1337636757 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1337650827 |
CABP2
|
Health Risk |
Likely pathogenic |
— |
| RS1337668635 |
WDR73
|
Health Risk |
Pathogenic |
— |
| RS1337669269 |
AQP2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS1337679118 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1337692923 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1337693743 |
PRR12
|
Health Risk |
Likely pathogenic |
Neuroocular syndrome, Neuroocular syndrome |
| RS1337695234 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1337698225 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS1337704280 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1337709383 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1337721316 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS1337742915 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1337751426 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1337758154 |
ATXN7
|
Health Risk |
Likely pathogenic |
Tip-toe gait, Tip-toe gait |
| RS1337761156 |
STIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to STIM1 deficiency, Myopathy with tubular aggregates |
| RS1337761270 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1337771339 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1337792814 |
PABPN1
|
Health Risk |
Pathogenic |
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |
| RS1337798545 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS1337798741 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS1337804475 |
AGBL5
|
Health Risk |
Likely pathogenic |
— |
| RS1337840598 |
USH1G
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS1337865963 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Neurodevelopmental disorder with hypotonia |
| RS1337874441 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1337890012 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS1337893429 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1337897299 |
CRYGD
|
Health Risk |
Pathogenic |
Cataract 4 multiple types, Aculeiform cataract |
| RS1337899996 |
EXOSC9
|
Health Risk |
Pathogenic |
— |
| RS1337918797 |
PJVK
|
Health Risk |
Likely pathogenic |
— |
| RS1337921591 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1337929727 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1337956293 |
PAX5
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1337995343 |
CTSA
|
Health Risk |
Pathogenic |
GALACTOSIALIDOSIS, LATE INFANTILE |
| RS1338018512 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1338023969 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1338038953 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1338061432 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne spectrum with or without cerebrooculofacioskeletal syndrome, Cockayne spectrum with or without cerebrooculofacioskeletal syndrome |
| RS1338074315 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS1338078012 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1338081758 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, ADGRV1-related disorder |
| RS1338085924 |
OCA2
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS1338125377 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1338132238 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Alstrom syndrome |
| RS1338132991 |
TNFRSF11A
|
Health Risk |
Pathogenic |
— |
| RS1338137742 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS1338138752 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1338169194 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS1338177551 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1338194519 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS1338200771 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1338201926 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1338210490 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS1338219387 |
ABCA3
|
Health Risk |
Pathogenic |
— |
| RS1338220455 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Cardiovascular phenotype |
| RS1338226967 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1338231889 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1338239866 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1338284039 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 4 |
| RS1338289178 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1338331744 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1338343514 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1338362749 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Bloom syndrome |
| RS1338364389 |
CTNS
|
Health Risk |
Pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS1338396929 |
RS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1338433423 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1338446830 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1338469029 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome |
| RS1338479649 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1338486619 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1338490917 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS1338491963 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1338494405 |
AK1
|
Health Risk |
Likely pathogenic |
— |
| RS1338495481 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS1338508417 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |